Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of ATR-107 Administered Subcutaneously And Intravenously To Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2012
At a glance
- Drugs ATR 107; ATR 107
- Indications Crohn's disease
- Focus Adverse reactions; Pharmacokinetics
- 14 Mar 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 22 Dec 2011 Actual patient number (70) added as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.